Illumina’s contentious acquisition of cancer test maker Grail brought billionaire Carl Icahn to the company’s doorstep. Read More
Recent Posts
- Dollar General CEO says consumers making $100,000 a year don’t feel like high-income shoppers anymore as high gas prices and inflation reshape habits
- Iran’s economy faces another blockade: Red tape and gridlock are clogging up land routes that bypass the U.S. Navy’s Hormuz stranglehold
- Canada and France in talks to deepen ties and ‘live our lives as we choose’ while Macron also seeks oil and gas as Iran war disrupts supplies
- U.S. economy hits pivotal milestone: Spending on data centers and other information-processing hardware now exceeds housing investment
- AI agents are agreeing and acting: machines are now smarter than humans. Their principals merely agree
Archives
- September 2026
- August 2026
- July 2026
- June 2026
- May 2026
- April 2026
- March 2026
- February 2026
- January 2026
- December 2025
- November 2025
- October 2025
- September 2025
- August 2025
- July 2025
- June 2025
- May 2025
- April 2025
- March 2025
- February 2025
- January 2025
- December 2024
- November 2024
- October 2024
- September 2024
- August 2024
- February 2024
- January 2024
- December 2023
- November 2023
- October 2023
- September 2023
- August 2023
- July 2023
- June 2023
- May 2023
- April 2023
- March 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
Recent Comments